Literature DB >> 7782434

In-vitro fertilization in completely natural cycles.

U M Fahy1, D J Cahill, P G Wardle, M G Hull.   

Abstract

Our objective was to assess the efficacy of in-vitro fertilization (IVF) in natural ovarian cycles in couples with tubal and unexplained infertility. A prospective study design was used. A total of 39 fully investigated couples, who were patients at the Reproductive Medicine Unit, St Michael's Hospital, Bristol, UK, took part; they were diagnosed with either tubal disease (n = 26) or unexplained infertility (n = 13). Procedures involved daily capillary blood sampling, daily vaginal ultrasonography and vaginal oocyte recovery under sedation at mid-cycle. The main outcome measures were fertilization, implantation and pregnancy rates. Although more of the women with tubal disease were parous, there were no other significant differences between the two groups. The 39 couples with infertility of tubal or unexplained aetiology had 79 cycles of IVF in otherwise completely natural cycles. The overall fertilization rate was 80% and the implantation rate was 14.0%. A trend was observed for higher success rates in women with tubal disease. We conclude that natural cycle IVF and embryo transfer offers an acceptable chance of pregnancy and an opportunity for the in-depth investigation of follicular and ovarian function in couples with defined causes of infertility. The possibly lower success rate in women with unexplained infertility warrants further study of follicular function and endocrinology.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7782434     DOI: 10.1093/oxfordjournals.humrep.a135991

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

1.  Early embryo mortality in natural human reproduction: What the data say.

Authors:  Gavin E Jarvis
Journal:  F1000Res       Date:  2016-11-25

2.  The preovulatory serum estradiol pattern in natural IVF/ICSI cycles.

Authors:  M Reljic; V Vlaisavljević
Journal:  J Assist Reprod Genet       Date:  1999-11       Impact factor: 3.412

3.  Establishment and application of criteria for the elective transfer of two good-quality embryos to reduce high-order multiple pregnancies.

Authors:  Hiroaki Shibahara; Tatsuya Suzuki; Yasuko Tanaka; Yuki Hirano; Akiyo Taneichi; Hiromi Obara; Hiroyuki Fujiwara; Satoru Takamizawa; Ikuo Sato
Journal:  Reprod Med Biol       Date:  2002-05-16

4.  Results of intracytoplasmic sperm injection of single oocyte in 362 unstimulated cycles.

Authors:  Veljko Vlaisavljević; Borut Kovacic; Milan Reljic; Vida Gavrić Lovrec; Mojca Cizek Sajko
Journal:  J Assist Reprod Genet       Date:  2002-03       Impact factor: 3.412

5.  The potential use of maturation in vitro of human oocytes in low responder patients.

Authors:  A Requena; F Neuspiller; A C Cobo; M Aragonés; J Remohí; C Simón; A Pellicer
Journal:  J Assist Reprod Genet       Date:  2000-05       Impact factor: 3.412

6.  GnRH antagonist for patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer in fresh cycles.

Authors:  Xiang-Hong Zhai; Ping Zhang; Feng-Xia Wu; An-Cong Wang; Pei-Shu Liu
Journal:  Exp Ther Med       Date:  2017-04-05       Impact factor: 2.447

7.  Comparison of Pregnancy Outcomes Between Fresh Embryo Transfer in a Natural IVF Cycle and IUI Cycle Among Infertile Young Women.

Authors:  Yoko Gekka; Koji Nakagawa; Hideaki Watanabe; Keiji Kuroda; Takashi Horikawa; Satoru Takamizawa; Rikikazu Sugiyama
Journal:  J Reprod Infertil       Date:  2022 Apr-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.